Systemic Mastocytosis With an Associated Hematologic Neoplasm
3 clinical trials · Condition
◉ Watch Systemic Mastocytosis With an Associated Hematologic Neoplasm
| Record | Firm | Date |
|---|---|---|
| (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (NCT03580655) | Blueprint Medicines Corporation | 2018-11-21 |
| Managed Access Programs for PKC412, Midostaurin (NCT05219266) | Novartis Pharmaceuticals |
Track Systemic Mastocytosis With an Associated Hematologic Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.